{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T10:09:30Z","timestamp":1792058970838,"version":"4.4.0"},"reference-count":352,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,2,1]]},"DOI":"10.1016\/j.crohns.2012.09.005","type":"journal-article","created":{"date-parts":[[2012,10,3]],"date-time":"2012-10-03T11:30:30Z","timestamp":1349263830000},"page":"1-33","source":"Crossref","is-referenced-by-count":396,"title":["Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 3: Special situations"],"prefix":"10.1093","volume":"7","author":[{"given":"Gert","family":"Van Assche","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Dignass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Bokemeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvio","family":"Danese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Gionchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Moser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Beaugerie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Gomoll\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winfried","family":"H\u00e4user","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Herrlinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bas","family":"Oldenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Panes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Portela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Rogler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert","family":"Tilg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Travis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James O.","family":"Lindsay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,2,1]]},"reference":[{"key":"2022082311454742300_bb0005","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/00000658-199508000-00003","article-title":"Ileal pouch-anal anastomoses complications and function in 1005 patients","volume":"222","author":"Fazio","year":"1995","journal-title":"Ann Surg"},{"key":"2022082311454742300_bb0010","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1016\/0016-5085(94)90832-X","article-title":"Pouchitis following ileal pouch-anal anastomosis: definition, pathogenesis, and treatment","volume":"107","author":"Sandborn","year":"1994","journal-title":"Gastroenterology"},{"key":"2022082311454742300_bb0015","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1001\/archsurg.1996.01430170043007","article-title":"Prospective study of the incidence, timing and treatment of pouchitis in 104 consecutive patients after restorative proctocolectomy","volume":"131","author":"Hurst","year":"1996","journal-title":"Arch Surg"},{"key":"2022082311454742300_bb0020","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1046\/j.1365-2168.1998.00689.x","article-title":"J ileal pouch-anal anastomosis for chronic ulcerative colitis: complications and long-term outcome in 1310 patients","volume":"85","author":"Meagher","year":"1998","journal-title":"Br J Surg"},{"key":"2022082311454742300_bb0025","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1136\/gut.38.2.234","article-title":"Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis","volume":"38","author":"Penna","year":"1996","journal-title":"Gut"},{"key":"2022082311454742300_bb0030","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s002680010136","article-title":"Risk factors and true incidence of pouchitis in patients after ileal pouch-anal anastomoses","volume":"24","author":"Simchuk","year":"2000","journal-title":"World J Surg"},{"key":"2022082311454742300_bb0035","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1111\/j.1572-0241.2005.00278.x","article-title":"Clinical approach to diseases of ileal pouch-anal anastomosis","volume":"100","author":"Shen","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"2022082311454742300_bb0040","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1007\/BF02054692","article-title":"Pouchitis following pelvic pouch operation for ulcerative colitis. Incidence, cumulative risk, and risk factors","volume":"39","author":"Stahlberg","year":"1996","journal-title":"Dis Colon Rectum"},{"key":"2022082311454742300_bb0045","doi-asserted-by":"crossref","first-page":"695","DOI":"10.3109\/00365529309098275","article-title":"Incidence and characteristics of pouchitis in the Kock continent ileostomy and the pelvic pouch","volume":"28","author":"Svaninger","year":"1993","journal-title":"Scand J Gastroenterol"},{"key":"2022082311454742300_bb0050","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/bjs.1800800638","article-title":"Function of ileal J pouch-anal anastomosis in patients with familial adenomatous polyposis","volume":"80","author":"Penna","year":"1993","journal-title":"Br J Surg"},{"key":"2022082311454742300_bb0055","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0002-9610(05)80834-7","article-title":"Similar functional results after restorative proctocolectomy in patients with familial adenomatous polyposis and mucosal ulcerative colitis","volume":"165","author":"Tjandra","year":"1993","journal-title":"Am J Surg"},{"key":"2022082311454742300_bb0060","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/BF01648830","article-title":"Restorative proctocolectomy with ileal reservoir","volume":"1","author":"Dozois","year":"1986","journal-title":"Int J Colorectal Dis"},{"key":"2022082311454742300_bb0065","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1001\/archsurg.1993.01420170030003","article-title":"Long-term results of the ileoanal pouch procedure","volume":"128","author":"Marcello","year":"1993","journal-title":"Arch Surg"},{"key":"2022082311454742300_bb0070","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000171597","article-title":"Ileo-anal pouch function and dysfunction","volume":"15","author":"Sagar","year":"1997","journal-title":"Dig Dis"},{"key":"2022082311454742300_bb0075","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1053\/gast.2001.26290","article-title":"Endoscopic and histologic evaluation together with symptom assessment are required to diagnose pouchitis","volume":"121","author":"Shen","year":"2001","journal-title":"Gastroenterology"},{"key":"2022082311454742300_bb0080","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1111\/j.1572-0241.2004.30518.x","article-title":"Treatment of rectal cuff inflammation (cuffitis) in patients with ulcerative colitis following restorative proctocolectomy and ileal pouch-anal anastomosis","volume":"99","author":"Shen","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"2022082311454742300_bb0085","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/BF01660720","article-title":"Pouchitis","volume":"3","author":"Tytgat","year":"1988","journal-title":"Int J Colorectal Dis"},{"key":"2022082311454742300_bb0090","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/0016-5085(93)90296-O","article-title":"The problem with pouchitis","volume":"104","author":"Pemberton","year":"1993","journal-title":"Gastroenterology"},{"key":"2022082311454742300_bb0095","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/BF01644986","article-title":"Pouchitis","volume":"4","author":"Shepherd","year":"1989","journal-title":"Int J Colorectal Dis"},{"key":"2022082311454742300_bb0100","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1111\/j.1572-0241.2002.05617.x","article-title":"Irritable pouch syndrome: a new category of diagnosis for symptomatic patients with ileal pouch-anal anastomosis","volume":"97","author":"Shen","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"2022082311454742300_bb0105","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1055\/s-2007-995784","article-title":"Endoscopy in the management of patients after ileal pouch surgery for ulcerative colitis","volume":"40","author":"Pardi","year":"2008","journal-title":"Endoscopy"},{"key":"2022082311454742300_bb0110","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/BF01648445","article-title":"An assessment of inflammation in the reservoir after restorative proctocolectomy with ileoanal ileal reservoir","volume":"1","author":"Moskowitz","year":"1986","journal-title":"Int J Colorectal Dis"},{"key":"2022082311454742300_bb0115","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/jcp.40.6.601","article-title":"Restorative proctocolectomy with ileal reservoir: pathological and histochemical study of mucosal biopsy specimens","volume":"40","author":"Shepherd","year":"1987","journal-title":"J Clin Pathol"},{"key":"2022082311454742300_bb0120","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s003840050144","article-title":"Patterns of distribution of endoscopic and histological changes in the ileal reservoir after restorative proctocolectomy for ulcerative colitis. A long-term follow-up study","volume":"13","author":"Setti Carraro","year":"1998","journal-title":"Int J Colorectal Dis"},{"key":"2022082311454742300_bb0125","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/gut.34.1.101","article-title":"Distribution of mucosal pathology and an assessment of colonic phenotypic change in the pelvic ileal reservoir","volume":"34","author":"Shepherd","year":"1993","journal-title":"Gut"},{"key":"2022082311454742300_bb0130","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1136\/gut.35.5.658","article-title":"Pouchitis: result of microbial imbalance?","volume":"35","author":"Ruseler-van Embden","year":"1994","journal-title":"Gut"},{"key":"2022082311454742300_bb0135","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1111\/j.1572-0241.2003.08719.x","article-title":"Tropomyosin expression in the ileal pouch: a relationship with the development of pouchitis in ulcerative colitis","volume":"98","author":"Biancone","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"2022082311454742300_bb0140","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1111\/j.1365-2036.2006.02884.x","article-title":"Systematic review: the management of pouchitis","volume":"23","author":"Pardi","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"2022082311454742300_bb0145","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.dld.2006.05.022","article-title":"Collagenous pouchitis","volume":"38","author":"Shen","year":"2006","journal-title":"Dig Liver Dis"},{"key":"2022082311454742300_bb0150","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1007\/s10620-006-9172-7","article-title":"Clostridium difficile-associated pouchitis","volume":"51","author":"Shen","year":"2006","journal-title":"Dig Dis Sci"},{"key":"2022082311454742300_bb0155","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1463-1318.2006.00954.x","article-title":"Pre-pouch ileitis: a disease of the ileum in ulcerative colitis after restorative proctocolectomy","volume":"8","author":"Bell","year":"2006","journal-title":"Colorectal Dis"},{"key":"2022082311454742300_bb0160","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1007\/s10620-006-9710-3","article-title":"Effect of withdrawal of nonsteroidal anti-inflammatory drug use on ileal pouch disorders","volume":"52","author":"Shen","year":"2007","journal-title":"Dig Dis Sci"},{"key":"2022082311454742300_bb0165","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1002\/ibd.21911","article-title":"Etiology of pouchitis","volume":"18","author":"Landy","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"2022082311454742300_bb0170","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1097\/00000658-199805000-00006","article-title":"Preoperative terminal ileal and colonic resection histopathology predicts risk of pouchitis in patients after ileoanal pull-through procedure","volume":"227","author":"Schmidt","year":"1998","journal-title":"Ann Surg"},{"key":"2022082311454742300_bb0175","first-page":"622","article-title":"Pouchitis and extraintestinal manifestations of inflammatory bowel disease after ileal pouch-anal anastomosis","volume":"211","author":"Lohmuller","year":"1990","journal-title":"Ann Surg"},{"key":"2022082311454742300_bb0180","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1136\/gut.38.3.362","article-title":"Smoking may prevent pouchitis in patients with restorative proctocolectomy for ulcerative colitis","volume":"38","author":"Merrett","year":"1996","journal-title":"Gut"},{"key":"2022082311454742300_bb0185","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S1542-3565(04)00604-4","article-title":"Differentiating risk factors for acute and chronic pouchitis","volume":"3","author":"Achkar","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2022082311454742300_bb0190","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1053\/gast.2001.28017","article-title":"The interleukin 1 receptor antagonist gene allele 2 as a predictor of pouchitis following colectomy and IPAA in ulcerative colitis","volume":"121","author":"Carter","year":"2001","journal-title":"Gastroenterology"},{"key":"2022082311454742300_bb0195","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1136\/gut.49.5.671","article-title":"High level perinuclear antineutrophil cytoplasmic antibody (pANCA) in ulcerative colitis patients before colectomy predicts the development of chronic pouchitis after ileal pouch-anal anastomosis","volume":"49","author":"Fleshner","year":"2001","journal-title":"Gut"},{"key":"2022082311454742300_bb0200","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.cgh.2005.10.004","article-title":"Risk factors for diseases of ileal pouch-anal anastomosis after restorative proctocolectomy for ulcerative colitis","volume":"4","author":"Shen","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2022082311454742300_bb1770","article-title":"Irritable pouch syndrome is characterized by visceral hypersensitivity","author":"Shen","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"2022082311454742300_bb0210","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/DCR.0b013e3181fded4d","article-title":"Perioperative factors during ileal pouch-anal anastomosis predict pouchitis","volume":"54","author":"Lipman","year":"2011","journal-title":"Dis Colon Rectum"},{"key":"2022082311454742300_bb0215","first-page":"51","article-title":"Pouchitis: risk factors, frequency, natural history, classification and public health perspective","author":"Sandborn","year":"1997","journal-title":"Trends in Inflammatory Bowel Disease"},{"key":"2022082311454742300_bb0220","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1002\/ibd.21039","article-title":"Clinical guidelines for the management of pouchitis","volume":"15","author":"Pardi","year":"2009","journal-title":"Inflamm Bowel Dis"},{"key":"2022082311454742300_bb0225","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0025-6196(12)61634-6","article-title":"Pouchitis after ileal pouch-anal anastomosis: a Pouchitis Disease Activity Index","volume":"69","author":"Sandborn","year":"1994","journal-title":"Mayo Clin Proc"},{"key":"2022082311454742300_bb0230","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1046\/j.1463-1318.2001.00211.x","article-title":"Comparison of the Moskowitz criteria and the pouchitis disease activity index (PDAI) for diagnosis of ileoanal pouch inflammation","volume":"3","author":"Evgenikos","year":"2001","journal-title":"Colorectal Dis"},{"key":"2022082311454742300_bb0235","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1007\/s10350-004-6297-7","article-title":"Diagnosing pouchitis: comparative validation of two scoring systems in routine follow-up","volume":"45","author":"Heuschen","year":"2002","journal-title":"Dis Colon Rectum"},{"key":"2022082311454742300_bb0240","first-page":"CD001176","article-title":"Pharmacotherapy for inducing and maintaining remission in pouchitis","author":"Sandborn","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"2022082311454742300_bb0245","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1007\/BF02093783","article-title":"Double-blind crossover trial of metronidazole versus placebo in chronic unremitting pouchitis","volume":"39","author":"Madden","year":"1994","journal-title":"Dig Dis Sci"},{"key":"2022082311454742300_bb0250","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/00054725-200111000-00004","article-title":"A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis","volume":"7","author":"Shen","year":"2001","journal-title":"Inflamm Bowel Dis"},{"key":"2022082311454742300_bb0255","first-page":"CD001176","article-title":"Treatment and prevention of pouchitis after ileal-pouch anal anastomosis for ulcerative colitis","volume":"6","author":"Holubar","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"2022082311454742300_bb0260","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1007\/s10350-006-0828-3","article-title":"Combined ciprofloxacin and tinidazole therapy in the treatment of chronic refractory pouchitis","volume":"50","author":"Shen","year":"2007","journal-title":"Dis Colon Rectum"},{"key":"2022082311454742300_bb0265","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1046\/j.1365-2036.1999.00553.x","article-title":"Antibiotic combination therapy in patients with chronic, treatment-resistant pouchitis","volume":"13","author":"Gionchetti","year":"1999","journal-title":"Aliment Pharmacol Ther"},{"key":"2022082311454742300_bb0270","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1463-1318.2004.00746.x","article-title":"Rifaximin-ciprofloxacin combination therapy is effective in chronic active refractory pouchitis","volume":"7","author":"Abdelrazeq","year":"2005","journal-title":"Colorectal Dis"},{"key":"2022082311454742300_bb0275","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1046\/j.1365-2036.2002.01203.x","article-title":"Four-week open-label trial of metronidazole and ciprofloxacin for the treatment of recurrent or refractory pouchitis","volume":"16","author":"Mimura","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"2022082311454742300_bb0280","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1111\/j.1365-2036.2007.03306.x","article-title":"Oral budesonide in the treatment of chronic refractory pouchitis","volume":"25","author":"Gionchetti","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"2022082311454742300_bb0285","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.crohns.2011.10.011","article-title":"Impact of budesonide on liver function tests and gut inflammation in patients with primary sclerosing cholangitis and ileal pouch anal anastomosis","volume":"6","author":"Navaneethan","year":"2012","journal-title":"J Crohns Colitis"},{"key":"2022082311454742300_bb0290","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1046\/j.1365-2036.2002.01139.x","article-title":"Budesonide enema in pouchitis\u2013a double-blind, double-dummy, controlled trial","volume":"16","author":"Sambuelli","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"2022082311454742300_bb0295","doi-asserted-by":"crossref","first-page":"701","DOI":"10.3109\/00365529309098276","article-title":"Cyclosporin A retention enemas in refractory distal ulcerative colitis and 'pouchitis'","volume":"28","author":"Winter","year":"1993","journal-title":"Scand J Gastroenterol"},{"key":"2022082311454742300_bb0300","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1056\/NEJM198911163212019","article-title":"Short-chain fatty acid irrigation in severe pouchitis","volume":"321","author":"de Silva","year":"1989","journal-title":"N Engl J Med"},{"key":"2022082311454742300_bb1775","first-page":"A784","article-title":"Short-chain fatty acid (SCFA) enema therapy for treatment-resistant pouchitis following ileal pouch-anal anastomosis (IPAA) for ulcerative colitis","volume":"106","author":"Tremaine","year":"1999","journal-title":"Gastroenterology"},{"key":"2022082311454742300_bb0310","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/S0025-6196(12)62270-8","article-title":"Chronic pouchitis after ileal pouch-anal anastomosis: responses to butyrate and glutamine suppositories in a pilot study","volume":"68","author":"Wischmeyer","year":"1993","journal-title":"Mayo Clin Proc"},{"key":"2022082311454742300_bb1780","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/ibd.21037","article-title":"Efficacy of infliximab in refractory pouchitis and Crohn's disease-related complications of the pouch: a Belgian case series","volume":"16","author":"Ferrante","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"2022082311454742300_bb1785","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/j.1365-2036.2008.03656.x","article-title":"Short-term treatment with infliximab in chronic refractory pouchitis and ileitis","volume":"27","author":"Calabrese","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"2022082311454742300_bb0325","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/ibd.21821","article-title":"Efficacy of infliximab rescue therapy in patients with chronic refractory pouchitis: a multicenter study","volume":"18","author":"Barreiro-de Acosta","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"2022082311454742300_bb0330","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1097\/MEG.0b013e3283525a7b","article-title":"Efficacy of adalimumab rescue therapy in patients with chronic refractory pouchitis previously treated with infliximab: a case series","volume":"24","author":"Barreiro-de Acosta","year":"2012","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2022082311454742300_bb0335","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-2036.2004.01863.x","article-title":"An enema formulation of alicaforsen, an antisense inhibitor of intercellular adhesion molecule-1, in the treatment of chronic, unremitting pouchitis","volume":"19","author":"Miner","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"2022082311454742300_bb0340","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1053\/gast.2000.9370","article-title":"Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial","volume":"119","author":"Gionchetti","year":"2000","journal-title":"Gastroenterology"},{"key":"2022082311454742300_bb0345","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1136\/gut.53.1.108","article-title":"Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis","volume":"53","author":"Mimura","year":"2004","journal-title":"Gut"},{"key":"2022082311454742300_bb0350","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/S0016-5085(03)00171-9","article-title":"Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial","volume":"124","author":"Gionchetti","year":"2003","journal-title":"Gastroenterology"},{"key":"2022082311454742300_bb0355","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1136\/gut.2005.078303","article-title":"Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis","volume":"55","author":"Kuhbacher","year":"2006","journal-title":"Gut"},{"key":"2022082311454742300_bb0360","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1572-0241.2005.40778.x","article-title":"Comprehensive evaluation of inflammatory and noninflammatory sequelae of ileal pouch-anal anastomoses","volume":"100","author":"Shen","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"2022082311454742300_bb0365","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/gut.48.4.526","article-title":"The risk of colorectal cancer in ulcerative colitis: a meta-analysis","volume":"48","author":"Eaden","year":"2001","journal-title":"Gut"},{"key":"2022082311454742300_bb0370","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1002\/1097-0142(19811215)48:12<2742::AID-CNCR2820481231>3.0.CO;2-P","article-title":"A comparison of cancer risk in Crohn's disease and ulcerative colitis","volume":"48","author":"Greenstein","year":"1981","journal-title":"Cancer"},{"key":"2022082311454742300_bb0375","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/ajg.2010.428","article-title":"The risk of inflammatory bowel disease-related colorectal carcinoma is limited: results from a nationwide nested case\u2013control study","volume":"106","author":"Baars","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"2022082311454742300_bb0380","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/S1542-3565(04)00543-9","article-title":"Long-term risk of cancer in ulcerative colitis: a population-based cohort study from Copenhagen County","volume":"2","author":"Winther","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2022082311454742300_bb0385","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1053\/j.gastro.2005.12.037","article-title":"Risk of intestinal cancer in inflammatory bowel disease: a population-based study from olmsted county, Minnesota","volume":"130","author":"Jess","year":"2006","journal-title":"Gastroenterology"},{"key":"2022082311454742300_bb0390","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1053\/j.gastro.2005.12.035","article-title":"Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis","volume":"130","author":"Rutter","year":"2006","journal-title":"Gastroenterology"},{"key":"2022082311454742300_bb0395","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1136\/gut.2007.143453","article-title":"High frequency of early colorectal cancer in inflammatory bowel disease","volume":"57","author":"Lutgens","year":"2008","journal-title":"Gut"},{"key":"2022082311454742300_bb0400","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/00054725-200311000-00002","article-title":"Gross versus microscopic pancolitis and the occurrence of neoplasia in ulcerative colitis","volume":"9","author":"Mathy","year":"2003","journal-title":"Inflamm Bowel Dis"},{"key":"2022082311454742300_bb0405","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jhep.2008.08.013","article-title":"High lifetime risk of cancer in primary sclerosing cholangitis","volume":"50","author":"Claessen","year":"2009","journal-title":"J Hepatol"},{"key":"2022082311454742300_bb0410","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2010.248","article-title":"Risk factors for neoplasia in inflammatory bowel disease patients with pancolitis","author":"Bergeron","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"2022082311454742300_bb0415","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1136\/gut.48.3.430","article-title":"Increased colorectal neoplasia in chronic ulcerative colitis complicated by primary sclerosing cholangitis: fact or fiction?","volume":"48","author":"Jayaram","year":"2001","journal-title":"Gut"},{"key":"2022082311454742300_bb0420","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1053\/j.gastro.2003.11.010","article-title":"Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis","volume":"126","author":"Rutter","year":"2004","journal-title":"Gastroenterology"},{"key":"2022082311454742300_bb0425","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1053\/j.gastro.2007.08.001","article-title":"Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study","volume":"133","author":"Gupta","year":"2007","journal-title":"Gastroenterology"},{"key":"2022082311454742300_bb0430","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/j.1572-0241.2007.01070.x","article-title":"Risk factors for colorectal neoplasia in inflammatory bowel disease: a nested case\u2013control study from Copenhagen county, Denmark and Olmsted county, Minnesota","volume":"102","author":"Jess","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"2022082311454742300_bb0435","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1053\/j.gastro.2006.03.028","article-title":"Predictive and protective factors associated with colorectal cancer in ulcerative colitis: a case\u2013control study","volume":"130","author":"Velayos","year":"2006","journal-title":"Gastroenterology"},{"key":"2022082311454742300_bb0440","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1136\/gut.29.2.206","article-title":"Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres","volume":"29","author":"Gyde","year":"1988","journal-title":"Gut"},{"key":"2022082311454742300_bb0445","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0016-5085(98)70077-0","article-title":"Familial predisposition for colorectal cancer in chronic ulcerative colitis: a case\u2013control study","volume":"115","author":"Nuako","year":"1998","journal-title":"Gastroenterology"},{"key":"2022082311454742300_bb0450","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/bjs.1800810520","article-title":"Colorectal cancer surveillance in patients with ulcerative colitis","volume":"81","author":"Jonsson","year":"1994","journal-title":"Br J Surg"},{"key":"2022082311454742300_bb0455","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/0016-5085(91)70010-U","article-title":"Cancer surveillance in ulcerative colitis","volume":"100","author":"Nugent","year":"1991","journal-title":"Gastroenterology"},{"key":"2022082311454742300_bb0460","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/0016-5085(90)90622-8","article-title":"Colonoscopic surveillance in long-standing total ulcerative colitis\u2014a 15-year follow-up study","volume":"99","author":"Lofberg","year":"1990","journal-title":"Gastroenterology"},{"key":"2022082311454742300_bb0465","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1046\/j.1365-2036.2000.00698.x","article-title":"Colorectal cancer prevention in ulcerative colitis: a case\u2013control study","volume":"14","author":"Eaden","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"2022082311454742300_bb0470","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/0016-5085(85)90653-5","article-title":"Surveillance for colonic carcinoma in ulcerative colitis","volume":"89","author":"Rosenstock","year":"1985","journal-title":"Gastroenterology"},{"key":"2022082311454742300_bb0475","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/00054725-199603000-00002","article-title":"Colorectal cancer in ulcerative colitis: survival in patients with and without colorectal cancer symptoms","volume":"2","author":"Giardiello","year":"1996","journal-title":"Inflamm Bowel Dis"},{"key":"2022082311454742300_bb0480","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1136\/gut.42.5.711","article-title":"Is colonoscopic surveillance reducing colorectal cancer mortality in ulcerative colitis? A population based case control study","volume":"42","author":"Karlen","year":"1998","journal-title":"Gut"},{"key":"2022082311454742300_bb0485","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/BF01537413","article-title":"Dysplasia and cancer complicating strictures in ulcerative colitis","volume":"35","author":"Lashner","year":"1990","journal-title":"Dig Dis Sci"},{"key":"2022082311454742300_bb0490","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/0016-5085(93)90715-O","article-title":"Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis","volume":"105","author":"Choi","year":"1993","journal-title":"Gastroenterology"},{"key":"2022082311454742300_bb0495","first-page":"CD000279","article-title":"Strategies for detecting colon cancer and\/or dysplasia in patients with inflammatory bowel disease","author":"Collins","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"2022082311454742300_bb0500","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1038\/sj.bjc.6605359","article-title":"Colonoscopic surveillance improves survival after colorectal cancer diagnosis in inflammatory bowel disease","volume":"101","author":"Lutgens","year":"2009","journal-title":"Br J Cancer"},{"key":"2022082311454742300_bb0505","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1136\/gut.52.8.1127","article-title":"Ten year follow up of ulcerative colitis patients with and without low grade dysplasia","volume":"52","author":"Lim","year":"2003","journal-title":"Gut"},{"key":"2022082311454742300_bb0510","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/0016-5085(94)90216-X","article-title":"Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis","volume":"107","author":"Connell","year":"1994","journal-title":"Gastroenterology"},{"key":"2022082311454742300_bb0515","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1067\/mge.2002.125367","article-title":"Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis","volume":"56","author":"Soetikno","year":"2002","journal-title":"Gastrointest Endosc"},{"key":"2022082311454742300_bb0520","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/0046-8177(89)90273-6","article-title":"Observer study of the grading of dysplasia in ulcerative colitis: comparison with clinical outcome","volume":"20","author":"Melville","year":"1989","journal-title":"Hum Pathol"},{"key":"2022082311454742300_bb0525","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1002\/ibd.20886","article-title":"More right-sided IBD-associated colorectal cancer in patients with primary sclerosing cholangitis","volume":"15","author":"Claessen","year":"2009","journal-title":"Inflamm Bowel Dis"},{"key":"2022082311454742300_bb0530","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/bjs.5811","article-title":"Systematic review of dysplasia after restorative proctocolectomy for ulcerative colitis","volume":"94","author":"Scarpa","year":"2007","journal-title":"Br J Surg"},{"key":"2022082311454742300_bb0535","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1055\/s-2006-925259","article-title":"Judgement of the quality of bowel preparation at screening flexible sigmoidoscopy is associated with variability in adenoma detection rates","volume":"38","author":"Thomas-Gibson","year":"2006","journal-title":"Endoscopy"},{"key":"2022082311454742300_bb0540","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/01.MIB.0000158951.54388.3a","article-title":"Endoscopic factors in the diagnosis of colorectal dysplasia in chronic inflammatory bowel disease","volume":"11","author":"Toruner","year":"2005","journal-title":"Inflamm Bowel Dis"},{"key":"2022082311454742300_bb0545","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.gie.2006.09.025","article-title":"Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?","volume":"65","author":"Rubin","year":"2007","journal-title":"Gastrointest Endosc"},{"key":"2022082311454742300_bb0550","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1136\/gut.2003.038505","article-title":"Cancer surveillance in longstanding ulcerative colitis: endoscopic appearances help predict cancer risk","volume":"53","author":"Rutter","year":"2004","journal-title":"Gut"},{"key":"2022082311454742300_bb0555","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S0016-5107(04)01710-9","article-title":"Most dysplasia in ulcerative colitis is visible at colonoscopy","volume":"60","author":"Rutter","year":"2004","journal-title":"Gastrointest Endosc"},{"key":"2022082311454742300_bb0560","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/0016-5085(92)91185-7","article-title":"DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis","volume":"103","author":"Rubin","year":"1992","journal-title":"Gastroenterology"},{"key":"2022082311454742300_bb0565","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1136\/gut.2008.169714","article-title":"Modelling dysplasia detection in ulcerative colitis: clinical implications of surveillance intensity","volume":"58","author":"Awais","year":"2009","journal-title":"Gut"},{"key":"2022082311454742300_bb0570","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1055\/s-2007-962987","article-title":"Surveillance colonoscopy in ulcerative colitis patients in Germany","volume":"45","author":"Kaltz","year":"2007","journal-title":"Z Gastroenterol"},{"key":"2022082311454742300_bb0575","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1155\/2009\/691850","article-title":"Adherence to guidelines for surveillance colonoscopy in patients with ulcerative colitis at a Canadian quaternary care hospital","volume":"23","author":"Kottachchi","year":"2009","journal-title":"Can J Gastroenterol"},{"key":"2022082311454742300_bb0580","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3748\/wjg.15.226","article-title":"Adherence to surveillance guidelines for dysplasia and colorectal carcinoma in ulcerative and Crohn's colitis patients in the Netherlands","volume":"15","author":"van Rijn","year":"2009","journal-title":"World J Gastroenterol"},{"key":"2022082311454742300_bb0585","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1053\/j.gastro.2010.07.039","article-title":"Prevalence of colorectal cancer surveillance for ulcerative colitis in an integrated health care delivery system","volume":"139","author":"Velayos","year":"2010","journal-title":"Gastroenterology"},{"key":"2022082311454742300_bb0590","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1053\/gast.2003.50146","article-title":"Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis","volume":"124","author":"Kiesslich","year":"2003","journal-title":"Gastroenterology"},{"key":"2022082311454742300_bb0595","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1136\/gut.2003.016386","article-title":"Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis","volume":"53","author":"Rutter","year":"2004","journal-title":"Gut"},{"key":"2022082311454742300_bb0600","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1055\/s-2007-966214","article-title":"Narrow-band imaging compared with conventional colonoscopy for the detection of dysplasia in patients with longstanding ulcerative colitis","volume":"39","author":"Dekker","year":"2007","journal-title":"Endoscopy"},{"key":"2022082311454742300_bb0605","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1055\/s-2005-921032","article-title":"Indigo carmine-assisted high-magnification chromoscopic colonoscopy for the detection and characterisation of intraepithelial neoplasia in ulcerative colitis: a prospective evaluation","volume":"37","author":"Hurlstone","year":"2005","journal-title":"Endoscopy"},{"key":"2022082311454742300_bb0610","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0016-5085(97)70215-4","article-title":"The effect of folic acid supplementation on the risk for cancer or dysplasia in ulcerative colitis","volume":"112","author":"Lashner","year":"1997","journal-title":"Gastroenterology"},{"key":"2022082311454742300_bb0615","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF02234825","article-title":"Proximal colorectal dysplasia or cancer in ulcerative colitis. The impact of primary sclerosing cholangitis and sulfasalazine: results from a 20-year surveillance study","volume":"44","author":"Lindberg","year":"2001","journal-title":"Dis Colon Rectum"},{"key":"2022082311454742300_bb0620","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1097\/00042737-199612000-00009","article-title":"Long-term therapy with sulphasalazine protects against colorectal cancer in ulcerative colitis: a retrospective study of colorectal cancer risk and compliance with treatment in Leicestershire","volume":"8","author":"Moody","year":"1996","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2022082311454742300_bb0625","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0016-5085(94)90068-X","article-title":"Risk factors for colorectal cancer in patients with ulcerative colitis: a case\u2013control study","volume":"107","author":"Pinczowski","year":"1994","journal-title":"Gastroenterology"},{"key":"2022082311454742300_bb0630","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1111\/j.1572-0241.2003.08718.x","article-title":"Does the use of 5-aminosalicylates in inflammatory bowel disease prevent the development of colorectal cancer?","volume":"98","author":"Bernstein","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"2022082311454742300_bb0635","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.cgh.2006.08.014","article-title":"Aminosalicylate therapy in the prevention of dysplasia and colorectal cancer in ulcerative colitis","volume":"4","author":"Rubin","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2022082311454742300_bb0640","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1136\/gut.2005.070896","article-title":"5-Aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological study","volume":"54","author":"van Staa","year":"2005","journal-title":"Gut"},{"key":"2022082311454742300_bb0645","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/ibd.20074","article-title":"5-Aminosalicylic acid therapy and the risk of colorectal cancer among patients with inflammatory bowel disease","volume":"13","author":"Terdiman","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"2022082311454742300_bb0650","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/ajg.2011.50","article-title":"5-Aminosalicylate is not chemoprophylactic for colorectal cancer in IBD: a population based study","volume":"106","author":"Bernstein","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"2022082311454742300_bb1790","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.crohns.2007.12.001","article-title":"ECCO f. European evidence based consensus on the management of ulcerative colitis: special situations","volume":"2","author":"Biancone","year":"2008","journal-title":"J Crohns Colitis"},{"key":"2022082311454742300_bb0660","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1053\/j.gastro.2009.12.037","article-title":"AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease","volume":"138","author":"Farraye","year":"2010","journal-title":"Gastroenterology"},{"key":"2022082311454742300_bb0665","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1136\/gut.2009.179804","article-title":"Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002)","volume":"59","author":"Cairns","year":"2010","journal-title":"Gut"},{"key":"2022082311454742300_bb0670","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1053\/j.gastro.2009.12.035","article-title":"AGA technical review on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease","volume":"138","author":"Farraye","year":"2010","journal-title":"Gastroenterology"},{"key":"2022082311454742300_bb1795","doi-asserted-by":"crossref","first-page":"A-54","DOI":"10.1016\/S0016-5085(09)60246-8","article-title":"Thiopurine therapy is associated with a three-fold decrease in the incidence of advanced colorectal neoplasia in IBD patients with longstanding extensive colitis: results from the CESAME cohort","volume":"136","author":"Beaugerie","year":"2009","journal-title":"Gastroenterology"},{"key":"2022082311454742300_bb0680","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1053\/j.gastro.2004.03.025","article-title":"Diagnosis and management of dysplasia in patients with inflammatory bowel diseases","volume":"126","author":"Itzkowitz","year":"2004","journal-title":"Gastroenterology"},{"key":"2022082311454742300_bb0685","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1365-2036.2009.04195.x","article-title":"Systematic review: molecular chemoprevention of colorectal malignancy by mesalazine","volume":"31","author":"Lyakhovich","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"2022082311454742300_bb0690","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.cgh.2008.05.020","article-title":"Progression to colorectal neoplasia in ulcerative colitis: effect of mesalamine","volume":"6","author":"Ullman","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2022082311454742300_bb0695","doi-asserted-by":"crossref","first-page":"89","DOI":"10.7326\/0003-4819-134-2-200101160-00008","article-title":"Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis","volume":"134","author":"Tung","year":"2001","journal-title":"Ann Intern Med"},{"key":"2022082311454742300_bb0700","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S1542-3565(05)00738-X","article-title":"Chemoprevention of colorectal neoplasia in ulcerative colitis: the effect of 6-mercaptopurine","volume":"3","author":"Matula","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2022082311454742300_bb0705","doi-asserted-by":"crossref","first-page":"S-693","DOI":"10.1016\/S0016-5085(10)63186-1","article-title":"Azathioprine (AZA) is associated with less histological inflammation of the colon in inactive IBD","volume":"138","author":"Bergeron","year":"2010","journal-title":"Gastroenterology"},{"key":"2022082311454742300_bb0710","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/S0140-6736(09)61302-7","article-title":"Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study","volume":"374","author":"Beaugerie","year":"2009","journal-title":"Lancet"},{"key":"2022082311454742300_bb0715","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1053\/gast.2003.50156","article-title":"Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis","volume":"124","author":"Pardi","year":"2003","journal-title":"Gastroenterology"},{"key":"2022082311454742300_bb0720","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1111\/j.1572-0241.1999.01201.x","article-title":"Adenomas and adenoma-like DALMs in chronic ulcerative colitis: a clinical, pathological, and molecular review","volume":"94","author":"Odze","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"2022082311454742300_bb0725","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S0046-8177(83)80175-0","article-title":"Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications","volume":"14","author":"Riddell","year":"1983","journal-title":"Hum Pathol"},{"key":"2022082311454742300_bb0730","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1002\/(SICI)1097-0142(19961201)78:11<2261::AID-CNCR1>3.0.CO;2-Q","article-title":"Significance and detection of dysplasia in chronic colitis","volume":"78","author":"Goldman","year":"1996","journal-title":"Cancer"},{"key":"2022082311454742300_bb0735","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/modpathol.3880534","article-title":"Interobserver variability in the diagnosis of ulcerative colitis-associated dysplasia by telepathology","volume":"15","author":"Odze","year":"2002","journal-title":"Mod Pathol"},{"key":"2022082311454742300_bb0740","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/path.876","article-title":"Inter-observer variation between general and specialist gastrointestinal pathologists when grading dysplasia in ulcerative colitis","volume":"194","author":"Eaden","year":"2001","journal-title":"J Pathol"},{"key":"2022082311454742300_bb0745","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/0016-5085(81)90727-7","article-title":"Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: an indication for colectomy","volume":"80","author":"Blackstone","year":"1981","journal-title":"Gastroenterology"},{"key":"2022082311454742300_bb0750","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1136\/gut.31.7.800","article-title":"Precancer and cancer in extensive ulcerative colitis: findings among 401 patients over 22 years","volume":"31","author":"Lennard-Jones","year":"1990","journal-title":"Gut"},{"key":"2022082311454742300_bb0755","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/BF01393356","article-title":"Macroscopic lesions in dysplasia and carcinoma complicating ulcerative colitis","volume":"28","author":"Butt","year":"1983","journal-title":"Dig Dis Sci"},{"key":"2022082311454742300_bb0760","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1136\/gut.2005.075531","article-title":"Sporadic adenoma in ulcerative colitis: endoscopic resection is an adequate treatment","volume":"55","author":"Vieth","year":"2006","journal-title":"Gut"},{"key":"2022082311454742300_bb0765","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/00000478-199803000-00001","article-title":"Polypoid dysplasia and adenomas in inflammatory bowel disease: a clinical, pathologic, and follow-up study of 89 polyps from 59 patients","volume":"22","author":"Torres","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"2022082311454742300_bb0770","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/BF02237486","article-title":"Differential diagnosis of dysplasia-associated lesion or mass and coincidental adenoma in ulcerative colitis","volume":"41","author":"Suzuki","year":"1998","journal-title":"Dis Colon Rectum"},{"key":"2022082311454742300_bb0775","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S1542-3565(04)00237-X","article-title":"Long-term follow-up after polypectomy treatment for adenoma-like dysplastic lesions in ulcerative colitis","volume":"2","author":"Odze","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2022082311454742300_bb0780","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0016-5085(99)70279-9","article-title":"Colonoscopic polypectomy in chronic colitis: conservative management after endoscopic resection of dysplastic polyps","volume":"117","author":"Rubin","year":"1999","journal-title":"Gastroenterology"},{"key":"2022082311454742300_bb0785","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/00054725-200307000-00006","article-title":"Management of neoplastic polyps in inflammatory bowel disease","volume":"9","author":"Friedman","year":"2003","journal-title":"Inflamm Bowel Dis"},{"key":"2022082311454742300_bb0790","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1136\/gut.2006.106294","article-title":"Endoscopic mucosal resection for flat neoplasia in chronic ulcerative colitis: can we change the endoscopic management paradigm?","volume":"56","author":"Hurlstone","year":"2007","journal-title":"Gut"},{"key":"2022082311454742300_bb0795","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/S0016-5085(99)70278-7","article-title":"Polypectomy may be adequate treatment for adenoma-like dysplastic lesions in chronic ulcerative colitis","volume":"117","author":"Engelsgjerd","year":"1999","journal-title":"Gastroenterology"},{"key":"2022082311454742300_bb0800","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0140-6736(94)90813-3","article-title":"Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis?","volume":"343","author":"Bernstein","year":"1994","journal-title":"Lancet"},{"key":"2022082311454742300_bb0805","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1038\/sj.bjc.6601247","article-title":"Earlier surveillance colonoscopy programme improves survival in patients with ulcerative colitis associated colorectal cancer: results of a 23-year surveillance programme in the Japanese population","volume":"89","author":"Hata","year":"2003","journal-title":"Br J Cancer"},{"key":"2022082311454742300_bb0810","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.gastro.2003.08.023","article-title":"Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis","volume":"125","author":"Ullman","year":"2003","journal-title":"Gastroenterology"},{"key":"2022082311454742300_bb0815","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1365-2036.2007.03241.x","article-title":"Meta-analysis: cancer risk of low-grade dysplasia in chronic ulcerative colitis","volume":"25","author":"Thomas","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"2022082311454742300_bb0820","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1111\/j.1572-0241.2002.05610.x","article-title":"The fate of low grade dysplasia in ulcerative colitis","volume":"97","author":"Ullman","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"2022082311454742300_bb0825","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s10350-004-6255-4","article-title":"Low-grade dysplasia in extensive, long-standing inflammatory bowel disease: a follow-up study","volume":"45","author":"Befrits","year":"2002","journal-title":"Dis Colon Rectum"},{"key":"2022082311454742300_bb0830","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/ibd.20873","article-title":"Depression and anxiety in inflammatory bowel disease: a review of comorbidity and management","volume":"15","author":"Graff","year":"2009","journal-title":"Inflamm Bowel Dis"},{"key":"2022082311454742300_bb0835","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000226087","article-title":"The role of psychological stress in inflammatory bowel disease: quality assessment of methods of 18 prospective studies and suggestions for future research","volume":"80","author":"Camara","year":"2009","journal-title":"Digestion"},{"issue":"Suppl. 1","key":"2022082311454742300_bb0840","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1159\/000268124","article-title":"Does stress influence inflammatory bowel disease? The clinical data","volume":"27","author":"Rampton","year":"2009","journal-title":"Dig Dis"},{"key":"2022082311454742300_bb0845","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2174\/156652408784533832","article-title":"The role of stress in the development and clinical course of inflammatory bowel disease: epidemiological evidence","volume":"8","author":"Maunder","year":"2008","journal-title":"Curr Mol Med"},{"key":"2022082311454742300_bb0850","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/00006842-199805000-00007","article-title":"Presidential address: gastrointestinal illness and the biopsychosocial model","volume":"60","author":"Drossman","year":"1998","journal-title":"Psychosom Med"},{"key":"2022082311454742300_bb0855","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1126\/science.847460","article-title":"The need for a new medical model: a challenge for biomedicine","volume":"196","author":"Engel","year":"1977","journal-title":"Science"},{"key":"2022082311454742300_bb0860","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1136\/jech.55.10.716","article-title":"Depression and anxiety in people with inflammatory bowel disease","volume":"55","author":"Kurina","year":"2001","journal-title":"J Epidemiol Community Health"},{"key":"2022082311454742300_bb0865","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1038\/ajg.2010.140","article-title":"A prospective population-based study of triggers of symptomatic flares in IBD","volume":"105","author":"Bernstein","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"2022082311454742300_bb0870","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/01.PSY.0000106907.24881.F2","article-title":"Impact of depressive mood on relapse in patients with inflammatory bowel disease: a prospective 18-month follow-up study","volume":"66","author":"Mittermaier","year":"2004","journal-title":"Psychosom Med"},{"key":"2022082311454742300_bb0875","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1572-0241.2006.00476.x","article-title":"Life events and inflammatory bowel disease relapse: a prospective study of patients enrolled in remission","volume":"101","author":"Vidal","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"2022082311454742300_bb0880","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/ibd.20062","article-title":"Controversies surrounding the comorbidity of depression and anxiety in inflammatory bowel disease patients: a literature review","volume":"13","author":"Mikocka-Walus","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"2022082311454742300_bb0885","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/01.MIB.0000160809.38611.f7","article-title":"Determinants of life satisfaction in inflammatory bowel disease","volume":"11","author":"Janke","year":"2005","journal-title":"Inflamm Bowel Dis"},{"key":"2022082311454742300_bb0890","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/ibd.20367","article-title":"The INSPIRE study: are different personality traits related to disease-specific quality of life (IBDQ) in distressed patients with ulcerative colitis and Crohn's disease?","volume":"14","author":"Boye","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"2022082311454742300_bb0895","article-title":"Socioeconomic and psychological factors associated with nonadherence to treatment in inflammatory bowel disease patients: results of the ISSEO survey","author":"Nahon","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"2022082311454742300_bb0900","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/ibd.21346","article-title":"Anxiety and depression in patients with inflammatory bowel disease: comparisons with chronic liver disease patients and the general population","volume":"17","author":"H\u00e4user","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"2022082311454742300_bb0905","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/00054725-200608000-00005","article-title":"Depression and inflammatory bowel disease: findings from two nationally representative Canadian surveys","volume":"12","author":"Fuller-Thomson","year":"2006","journal-title":"Inflamm Bowel Dis"},{"key":"2022082311454742300_bb0910","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1055\/s-0028-1109524","article-title":"Inflammatory bowel diseases as multi-focal disorders: results from a multi-regional survey on bodily and psychosocial problems in IBD patients","volume":"48","author":"Hardt","year":"2010","journal-title":"Z Gastroenterol"},{"key":"2022082311454742300_bb0915","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0002-9270(01)04037-0","article-title":"Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors","volume":"97","author":"Simren","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"2022082311454742300_bb0920","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1080\/00365520310004524","article-title":"Inflammatory bowel disease versus irritable bowel syndrome: a hospital-based, case\u2013control study of disease impact on quality of life","volume":"38","author":"Pace","year":"2003","journal-title":"Scand J Gastroenterol"},{"key":"2022082311454742300_bb0925","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.cgh.2005.12.012","article-title":"Coping strategies and interpersonal support in patients with irritable bowel syndrome and inflammatory bowel disease","volume":"4","author":"Jones","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2022082311454742300_bb0930","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1007\/BF01296620","article-title":"Health status and health care use in persons with inflammatory bowel disease. A national sample","volume":"36","author":"Drossman","year":"1991","journal-title":"Dig Dis Sci"},{"key":"2022082311454742300_bb0935","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1111\/j.1572-0241.2002.05969.x","article-title":"Psychosocial correlates of patient\u2013physician discordance in inflammatory bowel disease","volume":"97","author":"Sewitch","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"2022082311454742300_bb0940","first-page":"352","article-title":"Education of patients with inflammatory bowel diseases","volume":"149","author":"von Wietersheim","year":"1999","journal-title":"Wien Med Wochenschr"},{"key":"2022082311454742300_bb0945","first-page":"853","article-title":"Disease-related worries and concerns: a study on out-patients with inflammatory bowel disease","volume":"7","author":"Moser","year":"1995","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2022082311454742300_bb0950","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1002\/ibd.20198","article-title":"Internet use by patients in an inflammatory bowel disease specialty clinic","volume":"13","author":"Cima","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"2022082311454742300_bb0955","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1097\/MEG.0b013e328321b112","article-title":"Internet use among inflammatory bowel disease patients: an Italian multicenter survey","volume":"21","author":"Angelucci","year":"2009","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2022082311454742300_bb0960","first-page":"695","article-title":"Development of a Web-based concept for patients with ulcerative colitis and 5-aminosalicylic acid treatment","volume":"22","author":"Elkjaer","year":"2010","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2022082311454742300_bb0965","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1097\/00042737-199809000-00010","article-title":"Predictors of health care utilization in patients with inflammatory bowel disease: a longitudinal study","volume":"10","author":"de Boer","year":"1998","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2022082311454742300_bb0970","doi-asserted-by":"crossref","first-page":"4234","DOI":"10.3748\/wjg.15.4234","article-title":"Prevalence, predictors, and clinical consequences of medical adherence in IBD: how to improve it?","volume":"15","author":"Lakatos","year":"2009","journal-title":"World J Gastroenterol"},{"key":"2022082311454742300_bb0975","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1136\/gut.2003.034256","article-title":"A randomised controlled trial to assess the effectiveness and cost of a patient orientated self management approach to chronic inflammatory bowel disease","volume":"53","author":"Kennedy","year":"2004","journal-title":"Gut"},{"key":"2022082311454742300_bb0980","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S0140-6736(01)06105-0","article-title":"Guided self-management and patient-directed follow-up of ulcerative colitis: a randomised trial","volume":"358","author":"Robinson","year":"2001","journal-title":"Lancet"},{"key":"2022082311454742300_bb0985","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/00054725-200207000-00005","article-title":"Providing disease-related information worsens health-related quality of life in inflammatory bowel disease","volume":"8","author":"Borgaonkar","year":"2002","journal-title":"Inflamm Bowel Dis"},{"key":"2022082311454742300_bb1800","first-page":"411","article-title":"Patient education in inflammatory bowel disease","volume":"34","author":"Lange","year":"1996","journal-title":"Z Gastroenterol"},{"key":"2022082311454742300_bb0995","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1080\/00365520310003309","article-title":"A group-based patient education programme for high-anxiety patients with Crohn disease or ulcerative colitis","volume":"38","author":"Larsson","year":"2003","journal-title":"Scand J Gastroenterol"},{"key":"2022082311454742300_bb1000","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1055\/s-2004-813867","article-title":"Patient education in inflammatory bowel disease does not influence patients knowledge and long-term psychosocial well-being","volume":"43","author":"Bregenzer","year":"2005","journal-title":"Z Gastroenterol"},{"key":"2022082311454742300_bb1005","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/ibd.20061","article-title":"Group-based intervention program in inflammatory bowel disease patients: effects on quality of life","volume":"13","author":"Oxelmark","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"2022082311454742300_bb1010","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1080\/00365520701439685","article-title":"A multiprofessional education programme for patients with inflammatory bowel disease: a randomized controlled trial","volume":"42","author":"Jaghult","year":"2007","journal-title":"Scand J Gastroenterol"},{"key":"2022082311454742300_bb1015","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/00054725-200409000-00021","article-title":"Assessing the demand for psychological care in chronic diseases: development and validation of a questionnaire based on the example of inflammatory bowel disease","volume":"10","author":"Miehsler","year":"2004","journal-title":"Inflamm Bowel Dis"},{"key":"2022082311454742300_bb1020","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/ibd.20256","article-title":"Factor analysis of ADAPT questionnaire for assessment of subjective need for psychological interventions","volume":"14","author":"Miehsler","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"2022082311454742300_bb1025","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1111\/j.1572-0241.2002.05842.x","article-title":"Psychological disorder and severity of inflammatory bowel disease predict health-related quality of life in ulcerative colitis and Crohn's disease","volume":"97","author":"Guthrie","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"2022082311454742300_bb1030","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3109\/00365529309098355","article-title":"Quality of life\u2014measurement in inflammatory bowel disease","volume":"199","author":"Irvine","year":"1993","journal-title":"Scand J Gastroenterol Suppl"},{"key":"2022082311454742300_bb1035","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1097\/00006842-199111000-00010","article-title":"The rating form of IBD patient concerns: a new measure of health status","volume":"53","author":"Drossman","year":"1991","journal-title":"Psychosom Med"},{"key":"2022082311454742300_bb1040","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1111\/j.1572-0241.2001.03800.x","article-title":"Psychological distress, social support, and disease activity in patients with inflammatory bowel disease","volume":"96","author":"Sewitch","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"2022082311454742300_bb1045","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/ibd.21098","article-title":"Does psychological counseling alter the natural history of inflammatory bowel disease?","volume":"16","author":"Wahed","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"2022082311454742300_bb1050","doi-asserted-by":"crossref","first-page":"174","DOI":"10.4321\/S1130-01082004000300003","article-title":"The opinion of patients with inflammatory bowel disease on healthcare received","volume":"96","author":"Casellas","year":"2004","journal-title":"Rev Esp Enferm Dig"},{"key":"2022082311454742300_bb1055","first-page":"286","article-title":"An evaluation of the effectiveness of psychotherapy in the treatment of ulcerative colitis","volume":"71","author":"Patterson","year":"1964","journal-title":"Gastroenterology"},{"key":"2022082311454742300_bb1060","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1080\/00365520310003110","article-title":"Reducing psychological distress in patients with inflammatory bowel disease by cognitive-behavioural treatment: exploratory study of effectiveness","volume":"38","author":"Mussell","year":"2003","journal-title":"Scand J Gastroenterol"},{"key":"2022082311454742300_bb1065","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0005-7967(91)90045-5","article-title":"Evaluation of a psychological treatment for inflammatory bowel disease","volume":"29","author":"Schwarz","year":"1991","journal-title":"Behav Res Ther"},{"key":"2022082311454742300_bb1075","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1365-2648.1986.tb01288.x","article-title":"A stress management program for inflammatory bowel disease","volume":"11","author":"Milne","year":"1986","journal-title":"J Adv Nurs"},{"key":"2022082311454742300_bb1080","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1159\/000086318","article-title":"Effects of mind-body therapy on quality of life and neuroendocrine and cellular immune functions in patients with ulcerative colitis","volume":"74","author":"Elsenbruch","year":"2005","journal-title":"Psychother Psychosom"},{"key":"2022082311454742300_bb1085","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1080\/00365520601101682","article-title":"Effects of a comprehensive lifestyle modification program on quality-of-life in patients with ulcerative colitis: a twelve-month follow-up","volume":"42","author":"Langhorst","year":"2007","journal-title":"Scand J Gastroenterol"},{"key":"2022082311454742300_bb1090","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0304-3959(87)90043-1","article-title":"Relaxation training as a treatment for chronic pain caused by ulcerative colitis","volume":"29","author":"Shaw","year":"1987","journal-title":"Pain"},{"key":"2022082311454742300_bb1095","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006913.pub2","article-title":"Psychological interventions for treatment of inflammatory bowel disease","author":"Timmer","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"2022082311454742300_bb1100","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1745-0179-2-24","article-title":"Antidepressants and inflammatory bowel disease: a systematic review","volume":"2","author":"Mikocka-Walus","year":"2006","journal-title":"Clin Pract Epidemiol Ment Health"},{"key":"2022082311454742300_bb1105","doi-asserted-by":"crossref","first-page":"7227","DOI":"10.3748\/wjg.v11.i46.7227","article-title":"Extraintestinal manifestations in inflammatory bowel disease","volume":"11","author":"Danese","year":"2005","journal-title":"World J Gastroenterol"},{"key":"2022082311454742300_bb1110","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/01.meg.0000243883.47938.aa","article-title":"Relationship between clinical features of Crohn's disease and the risk of developing extraintestinal manifestations","volume":"19","author":"Barreiro-de Acosta","year":"2007","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2022082311454742300_bb1115","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1136\/gut.42.3.387","article-title":"Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history","volume":"42","author":"Orchard","year":"1998","journal-title":"Gut"},{"key":"2022082311454742300_bb1120","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1155\/2001\/612531","article-title":"Muscoloskeletal manifestations in inflammatory bowel disease","volume":"15","author":"Fornaciari","year":"2001","journal-title":"Can J Gastroenterol"},{"key":"2022082311454742300_bb1125","first-page":"2860","article-title":"Spondyloarthropathy is underestimated in inflammatory bowel disease: prevalence and HLA association","volume":"27","author":"de Vlam","year":"2000","journal-title":"J Rheumatol"},{"key":"2022082311454742300_bb1130","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1440-1746.2007.05108.x","article-title":"Clinical and genetic factors associated with sacroiliitis in Crohn's disease","volume":"23","author":"Peeters","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"key":"2022082311454742300_bb1135","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s100670070003","article-title":"Subclinical sacroiliitis in inflammatory bowel disease: a clinical and follow-up study","volume":"19","author":"Queiro","year":"2000","journal-title":"Clin Rheumatol"},{"key":"2022082311454742300_bb1140","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780270401","article-title":"Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria","volume":"27","author":"van der Linden","year":"1984","journal-title":"Arthritis Rheum"},{"key":"2022082311454742300_bb1145","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1136\/ard.2003.019968","article-title":"Analysing chronic spinal changes in ankylosing spondylitis: a systematic comparison of conventional x rays with magnetic resonance imaging using established and new scoring systems","volume":"63","author":"Braun","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"2022082311454742300_bb1150","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1080\/03009740410005881","article-title":"MRI abnormalities of sacroiliac joints in early spondylarthropathy: a 1-year follow-up study","volume":"33","author":"Puhakka","year":"2004","journal-title":"Scand J Rheumatol"},{"key":"2022082311454742300_bb1155","first-page":"518","article-title":"Low back pain, sacroiliitis, and the relationship with HLA-B27 in Crohn's disease","volume":"30","author":"Steer","year":"2003","journal-title":"J Rheumatol"},{"key":"2022082311454742300_bb1160","first-page":"1482","article-title":"Meta-analysis of sulfasalazine in ankylosing spondylitis","volume":"17","author":"Ferraz","year":"1990","journal-title":"J Rheumatol"},{"key":"2022082311454742300_bb1165","first-page":"511","article-title":"Prevalence of ankylosing spondylitis and other spondyloarthropathies among patients with inflammatory bowel disease: a population study (the IBSEN study)","volume":"29","author":"Palm","year":"2002","journal-title":"J Rheumatol"},{"key":"2022082311454742300_bb1170","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1111\/j.1572-0241.2002.06064.x","article-title":"Improvement of arthritis and arthralgia after treatment with infliximab (Remicade) in a German prospective, open-label, multicenter trial in refractory Crohn's disease","volume":"97","author":"Herfarth","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"2022082311454742300_bb1175","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/S0140-6736(00)03239-6","article-title":"Crohn's disease associated with spondyloarthropathy: effect of TNF-alpha blockade with infliximab on articular symptoms","volume":"356","author":"Van den Bosch","year":"2000","journal-title":"Lancet"},{"key":"2022082311454742300_bb1180","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1136\/ard.2003.012450","article-title":"Infliximab in spondyloarthropathy associated with Crohn's disease: an open study on the efficacy of inducing and maintaining remission of musculoskeletal and gut manifestations","volume":"63","author":"Generini","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"2022082311454742300_bb1185","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/ard.62.1.74","article-title":"Efficacy of etanercept for treatment of Crohn's related spondyloarthritis but not colitis","volume":"62","author":"Marzo-Ortega","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"2022082311454742300_bb1190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1043-6618(02)00033-6","article-title":"Nonsteroidal anti-inflammatory drugs and inflammatory bowel disease: current perspectives","volume":"46","author":"Cipolla","year":"2002","journal-title":"Pharmacol Res"},{"key":"2022082311454742300_bb1195","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1111\/j.1572-0241.2000.02262.x","article-title":"Effects of nonsteroidal antiinflammatory drugs on inflammatory bowel disease: a case\u2013control study","volume":"95","author":"Felder","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"2022082311454742300_bb1200","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1097\/00054725-200411000-00009","article-title":"A long-term cohort study of nonsteroidal anti-inflammatory drug use and disease activity in outpatients with inflammatory bowel disease","volume":"10","author":"Bonner","year":"2004","journal-title":"Inflamm Bowel Dis"},{"key":"2022082311454742300_bb1205","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1572-0241.2006.00384.x","article-title":"The gastrointestinal safety and effect on disease activity of etoricoxib, a selective cox-2 inhibitor in inflammatory bowel diseases","volume":"101","author":"El Miedany","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"2022082311454742300_bb1210","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.cgh.2005.12.002","article-title":"Safety of celecoxib in patients with ulcerative colitis in remission: a randomized, placebo-controlled, pilot study","volume":"4","author":"Sandborn","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2022082311454742300_bb1215","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1002\/art.1780391209","article-title":"Comparison of sulfasalazine and placebo in the treatment of ankylosing spondylitis. A Department of Veterans Affairs Cooperative Study","volume":"39","author":"Clegg","year":"1996","journal-title":"Arthritis Rheum"},{"key":"2022082311454742300_bb1220","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/art.1780380507","article-title":"Sulfasalazine in the treatment of spondylarthropathy. A randomized, multicenter, double-blind, placebo-controlled study","volume":"38","author":"Dougados","year":"1995","journal-title":"Arthritis Rheum"},{"key":"2022082311454742300_bb1225","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/art.511","article-title":"Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (infliximab) versus placebo in active spondylarthropathy","volume":"46","author":"Van Den Bosch","year":"2002","journal-title":"Arthritis Rheum"},{"key":"2022082311454742300_bb1230","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1136\/ard.2005.041129","article-title":"Current evidence for the management of ankylosing spondylitis: a systematic literature review for the ASAS\/EULAR management recommendations in ankylosing spondylitis","volume":"65","author":"Zochling","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"2022082311454742300_bb1235","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1136\/ard.2007.075879","article-title":"Persistent clinical efficacy and safety of anti-tumour necrosis factor alpha therapy with infliximab in patients with ankylosing spondylitis over 5 years: evidence for different types of response","volume":"67","author":"Braun","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"2022082311454742300_bb1240","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/S0140-6736(02)08215-6","article-title":"Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial","volume":"359","author":"Braun","year":"2002","journal-title":"Lancet"},{"key":"2022082311454742300_bb1245","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJMoa012664","article-title":"Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha","volume":"346","author":"Gorman","year":"2002","journal-title":"N Engl J Med"},{"key":"2022082311454742300_bb1250","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.1002\/art.23044","article-title":"Adalimumab significantly reduces both spinal and sacroiliac joint inflammation in patients with ankylosing spondylitis: a multicenter, randomized, double-blind, placebo-controlled study","volume":"56","author":"Lambert","year":"2007","journal-title":"Arthritis Rheum"},{"key":"2022082311454742300_bb1255","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/art.20852","article-title":"Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT)","volume":"52","author":"van der Heijde","year":"2005","journal-title":"Arthritis Rheum"},{"key":"2022082311454742300_bb1260","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1002\/art.21913","article-title":"Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial","volume":"54","author":"van der Heijde","year":"2006","journal-title":"Arthritis Rheum"},{"key":"2022082311454742300_bb1265","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.crohns.2008.01.005","article-title":"Osteoporosis in inflammatory bowel disease","volume":"2","author":"Reinshagen","year":"2008","journal-title":"J Crohns Colitis"},{"issue":"Suppl.","key":"2022082311454742300_bb1270","first-page":"27","article-title":"Technical aspects and clinical interpretation of bone mineral measurements","volume":"104","author":"Wahner","year":"1989","journal-title":"Public Health Rep"},{"key":"2022082311454742300_bb1275","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1136\/gut.51.5.654","article-title":"High prevalence of osteoporotic vertebral fractures in patients with Crohn's disease","volume":"51","author":"Klaus","year":"2002","journal-title":"Gut"},{"key":"2022082311454742300_bb1280","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.cgh.2007.02.024","article-title":"Vertebral fractures and role of low bone mineral density in Crohn's disease","volume":"5","author":"Siffledeen","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2022082311454742300_bb1285","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1046\/j.1365-2036.2002.01317.x","article-title":"Discordance between the degree of osteopenia and the prevalence of spontaneous vertebral fractures in Crohn's disease","volume":"16","author":"Stockbrugger","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"2022082311454742300_bb1290","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s001980170072","article-title":"An assessment tool for predicting fracture risk in postmenopausal women","volume":"12","author":"Black","year":"2001","journal-title":"Osteoporos Int"},{"key":"2022082311454742300_bb1295","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1365-2036.2010.04554.x","article-title":"Application of the WHO fracture risk assessment tool (FRAX) to predict need for DEXA scanning and treatment in patients with inflammatory bowel disease at risk of osteoporosis","volume":"33","author":"Goodhand","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"2022082311454742300_bb1300","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1001\/jama.293.18.2257","article-title":"Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials","volume":"293","author":"Bischoff-Ferrari","year":"2005","journal-title":"JAMA"},{"key":"2022082311454742300_bb1305","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1097\/00042737-200312000-00003","article-title":"Bone density improves with disease remission in patients with inflammatory bowel disease","volume":"15","author":"Reffitt","year":"2003","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2022082311454742300_bb1310","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.sder.2007.02.009","article-title":"Erythema nodosum","volume":"26","author":"Requena","year":"2007","journal-title":"Semin Cutan Med Surg"},{"key":"2022082311454742300_bb1315","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1136\/pgmj.2004.031633","article-title":"Important cutaneous manifestations of inflammatory bowel disease","volume":"81","author":"Trost","year":"2005","journal-title":"Postgrad Med J"},{"key":"2022082311454742300_bb1320","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1155\/2005\/323914","article-title":"Erythema nodosum and pyoderma gangrenosum in 50 patients with Crohn's disease","volume":"19","author":"Freeman","year":"2005","journal-title":"Can J Gastroenterol"},{"key":"2022082311454742300_bb1325","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1111\/j.1572-0241.2006.00504.x","article-title":"Inflammatory bowel disease characteristics among African Americans, Hispanics, and non-Hispanic Whites: characterization of a large North American cohort","volume":"101","author":"Nguyen","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"2022082311454742300_bb1330","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1600-0560.2007.00849.x","article-title":"Metastatic Crohn's disease: a histopathologic study of 12 cases","volume":"35","author":"Emanuel","year":"2008","journal-title":"J Cutan Pathol"},{"key":"2022082311454742300_bb1335","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1053\/gast.2002.35396","article-title":"Uveitis and erythema nodosum in inflammatory bowel disease: clinical features and the role of HLA genes","volume":"123","author":"Orchard","year":"2002","journal-title":"Gastroenterology"},{"key":"2022082311454742300_bb1340","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1365-2230.2006.02221.x","article-title":"Treatment of chronic erythema nodosum with infliximab","volume":"31","author":"Clayton","year":"2006","journal-title":"Clin Exp Dermatol"},{"key":"2022082311454742300_bb1345","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1468-3083.2006.01893.x","article-title":"Refractory chronic erythema nodosum successfully treated with adalimumab","volume":"21","author":"Ortego-Centeno","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2022082311454742300_bb1350","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.rdc.2007.07.016","article-title":"Pyoderma gangrenosum: an update","volume":"33","author":"Callen","year":"2007","journal-title":"Rheum Dis Clin North Am"},{"key":"2022082311454742300_bb1355","first-page":"88","article-title":"Clinical manifestations of pyoderma gangrenosum associated with inflammatory bowel disease","volume":"6","author":"Menachem","year":"2004","journal-title":"Isr Med Assoc J"},{"key":"2022082311454742300_bb1360","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1056\/NEJMoa013383","article-title":"Skin ulcers misdiagnosed as pyoderma gangrenosum","volume":"347","author":"Weenig","year":"2002","journal-title":"N Engl J Med"},{"key":"2022082311454742300_bb1365","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/bmj.333.7560.181","article-title":"Diagnosis and treatment of pyoderma gangrenosum","volume":"333","author":"Brooklyn","year":"2006","journal-title":"BMJ"},{"key":"2022082311454742300_bb1370","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000111029","article-title":"Extraintestinal manifestations of Crohn's disease","volume":"76","author":"Juillerat","year":"2007","journal-title":"Digestion"},{"key":"2022082311454742300_bb1375","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1001\/archderm.1992.01680180054005","article-title":"Treatment of pyoderma gangrenosum with cyclosporine","volume":"128","author":"Matis","year":"1992","journal-title":"Arch Dermatol"},{"key":"2022082311454742300_bb1380","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1046\/j.1365-2036.2003.01534.x","article-title":"Rescue therapy with tacrolimus is effective in patients with severe and refractory inflammatory bowel disease","volume":"17","author":"Baumgart","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"2022082311454742300_bb1385","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1111\/j.1572-0241.2003.07581.x","article-title":"Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease","volume":"98","author":"Regueiro","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"2022082311454742300_bb1390","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1136\/gut.2005.074815","article-title":"Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial","volume":"55","author":"Brooklyn","year":"2006","journal-title":"Gut"},{"key":"2022082311454742300_bb1395","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.jamcollsurg.2007.07.023","article-title":"Management of peristomal pyoderma gangrenosum","volume":"206","author":"Poritz","year":"2008","journal-title":"J Am Coll Surg"},{"key":"2022082311454742300_bb1400","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1750-1172-2-34","article-title":"Sweet's syndrome\u2014a comprehensive review of an acute febrile neutrophilic dermatosis","volume":"2","author":"Cohen","year":"2007","journal-title":"Orphanet J Rare Dis"},{"key":"2022082311454742300_bb1405","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/00042737-199707000-00013","article-title":"Sweet's syndrome: an unusual cutaneous feature of Crohn's disease or ulcerative colitis. The South West Gastroenterology Group","volume":"9","author":"Travis","year":"1997","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2022082311454742300_bb1410","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000088466","article-title":"Sweet's syndrome\u2014an extraintestinal manifestation in inflammatory bowel disease","volume":"72","author":"Ytting","year":"2005","journal-title":"Digestion"},{"key":"2022082311454742300_bb1415","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/j.1365-2036.2009.03955.x","article-title":"Review article: anti TNF-alpha induced psoriasis in patients with inflammatory bowel disease","volume":"29","author":"Fiorino","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"2022082311454742300_bb1420","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.cgh.2010.07.022","article-title":"Severe skin lesions cause patients with inflammatory bowel disease to discontinue anti-tumor necrosis factor therapy","volume":"8","author":"Rahier","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2022082311454742300_bb1425","doi-asserted-by":"crossref","DOI":"10.1038\/nrgastro.2012.125","article-title":"Paradoxical inflammation induced by anti-TNF agents in patients with IBD","author":"Cleynen","year":"2012","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2022082311454742300_bb1430","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.semarthrit.2010.04.003","article-title":"Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: clinical features and possible immunopathogenesis","volume":"40","author":"Collamer","year":"2010","journal-title":"Semin Arthritis Rheum"},{"key":"2022082311454742300_bb1435","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1002\/art.23835","article-title":"Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: a literature review and potential mechanisms of action","volume":"59","author":"Collamer","year":"2008","journal-title":"Arthritis Rheum"},{"key":"2022082311454742300_bb1440","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/00054725-200403000-00012","article-title":"Ocular manifestations of inflammatory bowel disease","volume":"10","author":"Mintz","year":"2004","journal-title":"Inflamm Bowel Dis"},{"key":"2022082311454742300_bb1445","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1572-0241.2006.00947.x","article-title":"Abnormal hepatic biochemistries in patients with inflammatory bowel disease","volume":"102","author":"Mendes","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"2022082311454742300_bb1450","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2214\/ajr.178.2.1780327","article-title":"Comparison of MR cholangiopancreatographic techniques with contrast-enhanced cholangiography in the evaluation of sclerosing cholangitis","volume":"178","author":"Vitellas","year":"2002","journal-title":"AJR Am J Roentgenol"},{"key":"2022082311454742300_bb1455","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/hep.20287","article-title":"Cost-minimization analysis of MRC versus ERCP for the diagnosis of primary sclerosing cholangitis","volume":"40","author":"Talwalkar","year":"2004","journal-title":"Hepatology"},{"key":"2022082311454742300_bb1460","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1055\/s-2006-933563","article-title":"The medical management of primary sclerosing cholangitis","volume":"26","author":"Cullen","year":"2006","journal-title":"Semin Liver Dis"},{"key":"2022082311454742300_bb1465","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1056\/NEJM199703063361003","article-title":"Ursodiol for primary sclerosing cholangitis. Mayo Primary Sclerosing Cholangitis-Ursodeoxycholic Acid Study Group","volume":"336","author":"Lindor","year":"1997","journal-title":"N Engl J Med"},{"key":"2022082311454742300_bb1470","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1053\/gast.2001.27965","article-title":"A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis","volume":"121","author":"Mitchell","year":"2001","journal-title":"Gastroenterology"},{"key":"2022082311454742300_bb1475","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/hep.23082","article-title":"High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"key":"2022082311454742300_bb1480","first-page":"3121","article-title":"Ursodeoxycholic acid treatment in IBD-patients with colorectal dysplasia and\/or DNA-aneuploidy: a prospective, double-blind, randomized controlled pilot study","volume":"24","author":"Sjoqvist","year":"2004","journal-title":"Anticancer Res"},{"key":"2022082311454742300_bb1485","first-page":"455","article-title":"Tacrolimus (FK 506), a treatment for primary sclerosing cholangitis: results of an open-label preliminary trial","volume":"90","author":"Van Thiel","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"2022082311454742300_bb1490","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/hep.510290427","article-title":"Recurrence of primary sclerosing cholangitis following liver transplantation","volume":"29","author":"Graziadei","year":"1999","journal-title":"Hepatology"},{"key":"2022082311454742300_bb1495","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1155\/2007\/924257","article-title":"Hospitalization-based major comorbidity of inflammatory bowel disease in Canada","volume":"21","author":"Bernstein","year":"2007","journal-title":"Can J Gastroenterol"},{"key":"2022082311454742300_bb1500","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1136\/gut.2003.025411","article-title":"Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism?","volume":"53","author":"Miehsler","year":"2004","journal-title":"Gut"},{"key":"2022082311454742300_bb1505","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1111\/j.1572-0241.2008.02052.x","article-title":"Rising prevalence of venous thromboembolism and its impact on mortality among hospitalized inflammatory bowel disease patients","volume":"103","author":"Nguyen","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"2022082311454742300_bb1510","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1572-0241.2006.00943.x","article-title":"Inflammation and coagulation in inflammatory bowel disease: the clot thickens","volume":"102","author":"Danese","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"2022082311454742300_bb1515","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1055\/s-0037-1615600","article-title":"The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study","volume":"85","author":"Bernstein","year":"2001","journal-title":"Thromb Haemost"},{"key":"2022082311454742300_bb1520","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1136\/gut.2010.228585","article-title":"Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study","volume":"60","author":"Kappelman","year":"2011","journal-title":"Gut"},{"key":"2022082311454742300_bb1525","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1053\/j.gastro.2010.05.026","article-title":"Inflammatory bowel disease is a risk factor for recurrent venous thromboembolism","volume":"139","author":"Novacek","year":"2009","journal-title":"Gastroenterology"},{"key":"2022082311454742300_bb1805","first-page":"1301","volume":"21","year":"2000","journal-title":"Guidelines on diagnosis and management of acute pulmonary embolism. Task Force on Pulmonary Embolism, European Society of Cardiology"},{"key":"2022082311454742300_bb1535","doi-asserted-by":"crossref","first-page":"454","DOI":"10.7326\/0003-4819-146-6-200703200-00013","article-title":"Current diagnosis of venous thromboembolism in primary care: a clinical practice guideline from the American Academy of Family Physicians and the American College of Physicians","volume":"146","author":"Qaseem","year":"2007","journal-title":"Ann Intern Med"},{"key":"2022082311454742300_bb1810","first-page":"101","volume":"25","year":"2006","journal-title":"Prevention and treatment of venous thromboembolism. International Consensus Statement (guidelines according to scientific evidence)"},{"key":"2022082311454742300_bb1545","doi-asserted-by":"crossref","first-page":"454S","DOI":"10.1378\/chest.08-0658","article-title":"Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)","volume":"133","author":"Kearon","year":"2008","journal-title":"Chest"},{"key":"2022082311454742300_bb1550","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1365-2036.2007.03418.x","article-title":"Meta-analysis: the utility and safety of heparin in the treatment of active ulcerative colitis","volume":"26","author":"Shen","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"2022082311454742300_bb1555","doi-asserted-by":"crossref","first-page":"381S","DOI":"10.1378\/chest.08-0656","article-title":"Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)","volume":"133","author":"Geerts","year":"2008","journal-title":"Chest"},{"key":"2022082311454742300_bb1560","doi-asserted-by":"crossref","first-page":"278","DOI":"10.7326\/0003-4819-146-4-200702200-00007","article-title":"Meta-analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients","volume":"146","author":"Dentali","year":"2007","journal-title":"Ann Intern Med"},{"key":"2022082311454742300_bb1565","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1001\/archinte.164.9.963","article-title":"Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX Study","volume":"164","author":"Alikhan","year":"2004","journal-title":"Arch Intern Med"},{"key":"2022082311454742300_bb1570","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJM199909093411103","article-title":"A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group","volume":"341","author":"Samama","year":"1999","journal-title":"N Engl J Med"},{"key":"2022082311454742300_bb1815","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/00054725-200005000-00013","article-title":"Anemia in IBD: the overlooked villain","volume":"6","author":"Gasche","year":"2000","journal-title":"Inflamm Bowel Dis"},{"key":"2022082311454742300_bb1820"},{"key":"2022082311454742300_bb1585","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1111\/j.1572-0241.2008.01846.x","article-title":"Common misconceptions in the diagnosis and management of anemia in inflammatory bowel disease","volume":"103","author":"Gisbert","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"2022082311454742300_bb1590","doi-asserted-by":"crossref","first-page":"17063","DOI":"10.1073\/pnas.0708160104","article-title":"Evolution of adverse changes in stored RBCs","volume":"104","author":"Bennett-Guerrero","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022082311454742300_bb1595","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/01.MIB.0000196646.64615.db","article-title":"Effects of changes in hemoglobin level on quality of life and cognitive function in inflammatory bowel disease patients","volume":"12","author":"Wells","year":"2006","journal-title":"Inflamm Bowel Dis"},{"key":"2022082311454742300_bb1600","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1007\/s00268-003-6972-1","article-title":"Preoperative steroid administration: effect on morbidity among patients undergoing intestinal bowel resection for Crohns disease","volume":"27","author":"Bruewer","year":"2003","journal-title":"World J Surg"},{"key":"2022082311454742300_bb1605","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1111\/j.1365-2036.2006.03146.x","article-title":"Systematic review: managing anaemia in Crohn's disease","volume":"24","author":"Kulnigg","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"2022082311454742300_bb1610","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1002\/ibd.20285","article-title":"Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases","volume":"13","author":"Gasche","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"2022082311454742300_bb1615","doi-asserted-by":"crossref","first-page":"4659","DOI":"10.3748\/wjg.15.4659","article-title":"Anemia and inflammatory bowel diseases","volume":"15","author":"Gomollon","year":"2009","journal-title":"World J Gastroenterol"},{"key":"2022082311454742300_bb1620"},{"key":"2022082311454742300_bb1625","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1111\/j.1365-3156.2008.02143.x","article-title":"Haemoglobin adjustments to define anaemia","volume":"13","author":"Sullivan","year":"2008","journal-title":"Trop Med Int Health"},{"key":"2022082311454742300_bb1630","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJMra041809","article-title":"Anemia of chronic disease","volume":"352","author":"Weiss","year":"2005","journal-title":"N Engl J Med"},{"key":"2022082311454742300_bb1635","doi-asserted-by":"crossref","first-page":"4638","DOI":"10.3748\/wjg.15.4638","article-title":"A guide to diagnosis of iron deficiency and iron deficiency anemia in digestive diseases","volume":"15","author":"Bermejo","year":"2009","journal-title":"World J Gastroenterol"},{"key":"2022082311454742300_bb1640","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/01.MIB.0000199223.27595.e3","article-title":"Ferritin as a simple indicator of iron deficiency in anemic IBD patients","volume":"12","author":"Guagnozzi","year":"2006","journal-title":"Inflamm Bowel Dis"},{"key":"2022082311454742300_bb1645","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.3748\/wjg.15.4617","article-title":"An update on iron physiology","volume":"15","author":"Munoz","year":"2009","journal-title":"World J Gastroenterol"},{"key":"2022082311454742300_bb1650","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1093\/clinchem\/48.7.1066","article-title":"Biochemical markers and hematologic indices in the diagnosis of functional iron deficiency","volume":"48","author":"Thomas","year":"2002","journal-title":"Clin Chem"},{"key":"2022082311454742300_bb1655","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1038\/ajg.2009.114","article-title":"Rapid recurrence of IBD-associated anemia and iron deficiency after intravenous iron sucrose and erythropoietin treatment","volume":"104","author":"Kulnigg","year":"2009","journal-title":"Am J Gastroenterol"},{"issue":"Suppl. 3\u20134","key":"2022082311454742300_bb1825","first-page":"IV1","article-title":"Guidelines for the management of iron deficiency anaemia. British Society of Gastroenterology","volume":"46","author":"Goddard","year":"2000","journal-title":"Gut"},{"key":"2022082311454742300_bb1830","first-page":"301","article-title":"Intravenous iron-dextran: therapeutic and experimental possibilities","volume":"100","author":"Ganzoni","year":"1970","journal-title":"Schweiz Med Wochenschr"},{"key":"2022082311454742300_bb1670","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1111\/j.1572-0241.2007.01744.x","article-title":"A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trial","volume":"103","author":"Kulnigg","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"2022082311454742300_bb1675","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/ajh.21154","article-title":"Intravenous iron: from anathema to standard of care","volume":"83","author":"Auerbach","year":"2008","journal-title":"Am J Hematol"},{"key":"2022082311454742300_bb1680","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1002\/ibd.20925","article-title":"Oral and intravenous iron treatment in inflammatory bowel disease: hematological response and quality of life improvement","volume":"15","author":"Gisbert","year":"2009","journal-title":"Inflamm Bowel Dis"},{"key":"2022082311454742300_bb1685","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1023\/A:1010726515401","article-title":"Effect of iron supplementation on oxidative stress and intestinal inflammation in rats with acute colitis","volume":"46","author":"Aghdassi","year":"2001","journal-title":"Dig Dis Sci"},{"key":"2022082311454742300_bb1690","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1093\/jn\/131.10.3146","article-title":"Iron supplementation increases disease activity and vitamin E ameliorates the effect in rats with dextran sulfate sodium-induced colitis","volume":"132","author":"Carrier","year":"2002","journal-title":"J Nutr"},{"key":"2022082311454742300_bb1695","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1046\/j.1365-2036.2001.01113.x","article-title":"Effect of oral iron supplementation on oxidative stress and colonic inflammation in rats with induced colitis","volume":"15","author":"Carrier","year":"2001","journal-title":"Aliment Pharmacol Ther"},{"key":"2022082311454742300_bb1700","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1080\/00365520510023198","article-title":"Oral ferrous fumarate or intravenous iron sucrose for patients with inflammatory bowel disease","volume":"40","author":"Erichsen","year":"2005","journal-title":"Scand J Gastroenterol"},{"key":"2022082311454742300_bb1705","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1093\/ndt\/gfi253","article-title":"Update on adverse drug events associated with parenteral iron","volume":"21","author":"Chertow","year":"2006","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl. 7A","key":"2022082311454742300_bb1710","doi-asserted-by":"crossref","first-page":"11S","DOI":"10.1016\/j.amjmed.2003.12.008","article-title":"Prevalence and outcomes of anemia in cancer: a systematic review of the literature","volume":"116","author":"Knight","year":"2004","journal-title":"Am J Med"},{"key":"2022082311454742300_bb1715","doi-asserted-by":"crossref","first-page":"782","DOI":"10.7326\/0003-4819-126-10-199705150-00006","article-title":"Intravenous iron and erythropoietin for anemia associated with Crohn disease. A randomized, controlled trial","volume":"126","author":"Gasche","year":"1997","journal-title":"Ann Intern Med"},{"key":"2022082311454742300_bb1720","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1080\/00365520902839667","article-title":"Intravenous iron sucrose is superior to oral iron sulphate for correcting anaemia and restoring iron stores in IBD patients: a randomized, controlled, evaluator-blind, multicentre study","volume":"44","author":"Lindgren","year":"2009","journal-title":"Scand J Gastroenterol"},{"key":"2022082311454742300_bb1725","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1111\/j.1572-0241.2005.00250.x","article-title":"Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease\u2013a randomized, controlled, open-label, multicenter study","volume":"100","author":"Schroder","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"2022082311454742300_bb1835","doi-asserted-by":"crossref","first-page":"4675","DOI":"10.3748\/wjg.15.4675","article-title":"Use of agents stimulating erythropoiesis in digestive diseases","volume":"15","author":"Moreno Lopez","year":"2009","journal-title":"World J Gastroenterol"},{"key":"2022082311454742300_bb1735","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/00042737-200604000-00017","article-title":"Effectiveness of darbepoetin-alfa in combination with intravenous iron sucrose in patients with inflammatory bowel disease and refractory anaemia: a pilot study","volume":"18","author":"Koutroubakis","year":"2006","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2022082311454742300_bb1740","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0140-6736(07)60194-9","article-title":"Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis","volume":"369","author":"Phrommintikul","year":"2007","journal-title":"Lancet"},{"key":"2022082311454742300_bb1745","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1681\/ASN.2009040444","article-title":"Resolved: targeting a higher hemoglobin is associated with greater risk in patients with CKD anemia: pro","volume":"20","author":"Singh","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"2022082311454742300_bb1750","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1182\/blood-2008-07-077370","article-title":"The hazards of blood transfusion in historical perspective","volume":"112","author":"Alter","year":"2008","journal-title":"Blood"},{"key":"2022082311454742300_bb1755","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1001\/archinte.168.21.2377","article-title":"Blood transfusions, thrombosis, and mortality in hospitalized patients with cancer","volume":"168","author":"Khorana","year":"2008","journal-title":"Arch Intern Med"},{"key":"2022082311454742300_bb1760","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0140-6736(05)17949-5","article-title":"Long-term survival after colorectal surgery associated with buffy-coat-poor and leucocyte-depleted blood transfusion: a follow-up study","volume":"365","author":"Jensen","year":"2005","journal-title":"Lancet"},{"key":"2022082311454742300_bb1765","doi-asserted-by":"crossref","first-page":"4686","DOI":"10.3748\/wjg.15.4686","article-title":"Blood transfusion for the treatment of acute anaemia in inflammatory bowel disease and other digestive diseases","volume":"15","author":"Garcia-Erce","year":"2009","journal-title":"World J Gastroenterol"}],"updated-by":[{"DOI":"10.1093\/ecco-jcc\/jjab227","type":"expression_of_concern","label":"Expression of concern","source":"retraction-watch","updated":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T00:00:00Z","timestamp":1642982400000},"record-id":"35061"}],"container-title":["Journal of Crohn's and Colitis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1873994612004060?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1873994612004060?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/7\/1\/1\/45500067\/ecco-jcc_7_1_1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/7\/1\/1\/45500067\/ecco-jcc_7_1_1.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T00:03:42Z","timestamp":1714435422000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article\/7\/1\/1\/398964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,1]]},"references-count":352,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2013,2,1]]},"published-print":{"date-parts":[[2013,2,1]]}},"URL":"https:\/\/doi.org\/10.1016\/j.crohns.2012.09.005","relation":{},"ISSN":["1876-4479","1873-9946"],"issn-type":[{"value":"1876-4479","type":"electronic"},{"value":"1873-9946","type":"print"}],"subject":[],"published-other":{"date-parts":[[2013,2]]},"published":{"date-parts":[[2013,2,1]]}}}